Endlyz Therapeutics
PrivateLast Round
Seed
Mar 31, 2026
Total Funding Raised
$18.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Endlyz Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2025.
Endlyz Therapeutics is a biotechnology company developing disease-modifying small-molecule therapeutics to restore endo-lysosomal function for the treatment of Parkinson's disease and other neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endlyz Therapeutics Comparables
Compare Endlyz Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Samsara Therapeutics | 88% | |
| Retromer Therapeutics | 85% | |
| Lysoway Therapeutics | 84% |
For institutional investors. Book with your work email.
Endlyz Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 31, 2026 | ||||
| Seed | Mar 31, 2025 | ||||
| Grant | Mar 31, 2025 | ||||
| Seed | Jul 16, 2021 |
For institutional investors. Book with your work email.
Endlyz Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Seed |
| Parkinson's UK | Seed |
| Oxford Science Enterprises | Seed |
| Centre for Drug Design and Discovery | Seed |
| AbbVie Ventures | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Oxford Science Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Raised $17.25M in early stage venture capital.
- Mar 31, 2025
Received $2.2M from The Michael J. Fox Foundation.
For institutional investors. Book with your work email.
Endlyz Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Endlyz Therapeutics's valuation, stock price, and market status.
Is Endlyz Therapeutics a public or private company?
Endlyz Therapeutics is a private company.
What is the current stock price of Endlyz Therapeutics?
Endlyz Therapeutics is a private company, so its shares have no public market price. Caplight tracks Endlyz Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Endlyz Therapeutics worth (valuation)?
Valuation information for Endlyz Therapeutics is not publicly available.
Can I buy Endlyz Therapeutics stock?
Endlyz Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Endlyz Therapeutics's last funding round?
Endlyz Therapeutics's most recent funding round was Seed on March 31, 2026.
Who are the main investors in Endlyz Therapeutics?
Key investors in Endlyz Therapeutics include SV Health Investors.
Will Endlyz Therapeutics IPO soon?
No public IPO plans have been announced for Endlyz Therapeutics.
How can I track Endlyz Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Endlyz Therapeutics's shares on secondary markets.